Clinical Trials Logo

Precancerous Conditions clinical trials

View clinical trials related to Precancerous Conditions.

Filter by:

NCT ID: NCT00522197 Completed - Lung Cancer Clinical Trials

ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia

Start date: September 2002
Phase: Phase 2
Study type: Interventional

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of ACAPHA, a combination of six herbs, may prevent lung cancer from forming in former smokers with bronchial intraepithelial neoplasia. PURPOSE: This randomized phase II trial is studying the side effects and how well ACAPHA works in preventing lung cancer in former smokers with bronchial intraepithelial neoplasia.

NCT ID: NCT00513526 Completed - Infection Clinical Trials

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Start date: November 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: Vaccines made from human papillomavirus may help the body build an effective immune response to kill HIV cells. PURPOSE: This phase II trial is studying the side effects and how well human papillomavirus vaccine therapy works in treating men with HIV-1 infection.

NCT ID: NCT00512746 Completed - Lung Cancer Clinical Trials

Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary Disease

Start date: August 2007
Phase: N/A
Study type: Interventional

RATIONALE: Screening tests or exams may help doctors find lung cancer sooner, when it may be easier to treat. PURPOSE: This randomized clinical trial is studying screening tests or exams to see how well they work compared to usual care in finding early stage lung cancer in current or past smokers with chronic obstructive pulmonary disease.

NCT ID: NCT00489671 Completed - Pancreatic Cancer Clinical Trials

Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis

Start date: June 2003
Phase: N/A
Study type: Observational

RATIONALE: Measuring cadmium levels in urine samples from patients with chronic pancreatitis may help doctors predict which patients may develop pancreatic cancer. It may also help the study of cancer in the future. PURPOSE: This clinical trial is studying urine cadmium levels in predicting pancreatic cancer risk in patients with chronic pancreatitis.

NCT ID: NCT00477880 Completed - Gastric Cancer Clinical Trials

Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer

Start date: April 2001
Phase: Phase 1
Study type: Interventional

RATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. PURPOSE: This clinical trial is studying how well cetuximab works in treating patients with Ménétrier disease at high risk of developing stomach cancer.

NCT ID: NCT00462813 Completed - Cervical Cancer Clinical Trials

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

Start date: October 2004
Phase: Phase 3
Study type: Interventional

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of diindolylmethane, a substance found in cruciferous vegetables, may keep cervical intraepithelial neoplasia or cervical cancer from forming. PURPOSE: This randomized phase III trial is studying diindolylmethane to see how well it works compared to a placebo in treating patients with abnormal cervical cells.

NCT ID: NCT00462280 Completed - Clinical trials for Precancerous Condition

Lovastatin in Treating Patients At High Risk of Melanoma

Start date: May 2007
Phase: Phase 2
Study type: Interventional

The use of lovastatin may slow disease progression in patients at high risk of melanoma. It is not yet known whether lovastatin is more effective than a placebo in treating patients at high risk of melanoma. This randomized phase II trial studies how well giving lovastatin or placebo works in treating patients at high risk of melanoma.

NCT ID: NCT00458562 Completed - Cervical Cancer Clinical Trials

Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer

Start date: January 2006
Phase: N/A
Study type: Observational

RATIONALE: Finding certain changes in genes may help doctors predict which patients are at risk of developing cervical intraepithelial neoplasia or invasive cervical cancer and may help the study of cancer in the future. PURPOSE: This clinical trial is studying genes that may predict which patients are at risk of developing cervical intraepithelial neoplasia or invasive cervical cancer.

NCT ID: NCT00453336 Completed - Clinical trials for Head and Neck Cancer

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract

Start date: June 2003
Phase: Phase 2
Study type: Interventional

RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, precancerous cells and cancer cells are killed. PURPOSE: This phase II trial is studying the side effects and how well photodynamic therapy with porfimer sodium works in treating patients with precancerous lesions, cancer, or other disease of the aerodigestive tract.

NCT ID: NCT00445718 Completed - Clinical trials for Precancerous Condition

Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging

Start date: July 2001
Phase: N/A
Study type: Observational

This natural history study is collecting health information about infants with adrenal masses found on prenatal and/or neonatal imaging. Gathering information over time from imaging and laboratory tests of infants with adrenal masses may help doctors learn more about the disease and plan the best treatment.